Researchers found that women who were given a gonadotropin-releasing hormone agonist, a fertility treatment that stimulates egg cell production, experienced symptoms of depression and anxiety regardless of whether they were given short- or long-term therapy to avoid the mood disturbances. The results "strongly argue against the possibility that GnRH-a exacerbates or induces mood symptoms during (IVF) cycles," the experts said.

Full Story:

Related Summaries